Abstract:Summary Sensory neuropeptides, released from the peripheral nervous system, might modulate glucose homeostasis by antagonizing insulin action. The effects of de-afferentation of functional small diameter unmyelinated C-fibres (sensory nerves) on in vivo insulin-mediated intracellular glucose metabolism were investigated by using euglycaemic insulin (6 and 18 mU/kg.min) clamps with [3-3H]-glucose infusion in 24 adult rats, treated neonatally with either capsaicin (CAP) (50 mg/kg) or vehicle (CON). Following the clamp, skeletal muscle groups, liver and adipose tissue were freeze-clamped. At plasma insulin levels of approximately 90 mU/l, CAP-rats showed a 21 % increase in whole body glucose uptake compared with CON (24.4 ± 1.6 vs 20.1 ± 0.8 mg/kg · min, p < 0.02), which was paralleled by a 20 % increase in whole body glycolysis (12.6 ± 0.8 vs 10.5 ± 0.5 mg/kg.min p < 0.05) (concentration of 3H2O in plasma). Whole body skeletal muscle glycogenesis was increased by 80 % in CAP-rats (5.7 ± 0.7 vs 3.1 ± 0.7 mg/kg · min, p < 0.05) with increased muscle glycogen synthase activity. Whole body (muscle, liver and adipose tissue combined) de novo lipogenesis also was increased in CAP-rats compared with CON (0.69 ± 0.10 vs 0.44 ± 0.06 mg/kg · min, p < 0.05) (incorporation of [3-3H]-glucose counts into glycogen or fat). Hepatic glucose production was lower in CAP-rats compared with CON (0.6 ± 0.6 vs 2.1 ± 0.7 mg/kg · min, p < 0.05). Plasma glucagon, corticosterone, epinephrine and norepinephrine levels were reduced in CAP-rats: 43 ± 2 compared with 70 ± 6 pg/ml, 855 ± 55 compared with 1131 ± 138 nmol/l, 513 ± 136 compared with 1048 ± 164 pmol/l and 928 ± 142 compared with 1472 ± 331 pmol/l, respectively, p < 0.05. At plasma insulin levels of approximately 400 mU/l, CAP-rats showed no differences in peripheral and hepatic insulin action compared with CON. We conclude that the removae of endogenous sensory neuropeptides, by de-afferentation of capsaicin-sensitive sensory nerves, increases in vivo insulin sensitivity, but not responsiveness: 1) primarily through an increased sensitivity of skeletal muscle glycogen synthesis to insulin; 2) through a reduction in the levels of counter-regulatory hormones, thereby creating a milieu which favours overall in vivo insulin sensitivity with respect to glucose uptake, glucose production, glycolysis, glycogenesis and lipogenesis. [Diabetologia (1998) 41: 813–820]

Effect of Epinephrine on Pancreatic β-cell and α-Cell Function in Patients With NIDDM

Improved post-prandial ghrelin response by nateglinide or acarbose therapy contributes to glucose stability in Type 2 diabetic patients

Chronic Epinephrine-Induced Endoplasmic Reticulum and Oxidative Stress Impairs Pancreatic β-Cells Function and Fate

Nateglinide and Acarbose Are Comparably Effective Reducers of Postprandial Glycemic Excursions in Chinese Antihyperglycemic Agent-Naive Subjects with Type 2 Diabetes

Polymorphonuclear Leukocytes in Non-Insulin-dependent Diabetes Mellitus: Abnormalities in Metabolism and Function

Effect of short-term intensive insulin therapy on α-cell function in patients with newly diagnosed type 2 diabetes.

Glp-1, Exendin-4 and C-Peptide Regulate Pancreatic Islet Microcirculation, Insulin Secretion and Glucose Tolerance in Rats

Beta-cell function and glucose metabolism in patients with chronic pancreatitis

The Effect of Hyperglycaemia on the Islet Β-Cell Responsiveness in Type 2 Diabetic Patients

Erythropoietin Improves Glucose Metabolism And Pancreatic Beta-Cell Damage In Experimental Diabetic Rats

[The Effects of Early Intensive Therapy on Islet Beta Cell Function and Long-Term Glycemia Control in Newly Diagnosed Type 2 Diabetic Patients with Different Fasting Plasma Glucose Levels.].

The effect of small increases in blood glucose on insulin secretion and endogenous glucose production in humans

[The Effects of Insulin and Gliclazide Therapy on Endoplasmic Reticulum Stress and Insulin Sensitivity in Liver of Type 2 Diabetic Rats].

Early insulin release effectively improves glucose tolerance: studies in two rodent models of type 2 diabetes mellitus

The effects of incretin-based therapies on beta-cell function and insulin resistance in type 2 diabetes: a systematic review and network meta-analysis combining 360 trials.

Effects of acute versus recurrent insulin-induced hypoglycemia on ventromedial hypothalamic nucleus metabolic-sensory neuron AMPK activity: Impact of alpha1-adrenergic receptor signaling

Effects of Dietary Fat and Protein on Glucoregulatory Hormones in Adolescents and Young Adults With Type 1 Diabetes

Neuropeptide Y1 receptor antagonism protects β-cells and improves glycemic control in type 2 diabetes

The effects of incretin-based therapies on β-cell function and insulin resistance in type 2 diabetes: A systematic review and network meta-analysis combining 360 trials

Neonatal de-afferentation of capsaicin-sensitive sensory nerves increases in vivo insulin sensitivity in conscious adult rats

1560-P: Inflammation in the Exocrine Pancreas Impairs Insulin Secretion